Evidence map›Paper›PMID 29651288›Full record

ArticleFrontiers in immunology2018

Nina K Serwas, Jakob Huemer, Régis Dieckmann, Ester Mejstrikova, Wojciech Garncarz, Jiri Litzman, Birgit Hoeger, Ondrej Zapletal, Ales Janda, Keiryn L Bennett and 3 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in Frontiers in immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Genetic susceptibility ofGlobal medical genetics · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 3 countries.

Nina K SerwasLudwig Boltzmann Institute for Rare and Undiagnosed Diseases, Vienna, Austria.
Jakob HuemerLudwig Boltzmann Institute for Rare and Undiagnosed Diseases, Vienna, Austria.
Régis DieckmannClinical Institute of Pathology, Medical University of Vienna, Vienna, Austria.
Ester MejstrikovaDepartment of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, University Hospital Motol, Prague, Czechia.
Wojciech GarncarzLudwig Boltzmann Institute for Rare and Undiagnosed Diseases, Vienna, Austria.
Jiri LitzmanDepartment of Clinical Immunology and Allergology, St. Anne's University Hospital, Faculty of Medicine, Masaryk University, Brno, Czechia.
Birgit HoegerLudwig Boltzmann Institute for Rare and Undiagnosed Diseases, Vienna, Austria.
Ondrej ZapletalDepartment of Pediatric Hematology, University Hospital Brno, Brno, Czechia.
Ales JandaCenter for Chronic Immunodeficiency (CCI), University Medical Center, University of Freiburg, Freiburg, Germany.
Keiryn L BennettCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
Renate KainClinical Institute of Pathology, Medical University of Vienna, Vienna, Austria.
Dontscho KerjaschkyClinical Institute of Pathology, Medical University of Vienna, Vienna, Austria.
Kaan BoztugLudwig Boltzmann Institute for Rare and Undiagnosed Diseases, Vienna, Austria.
Austrian Academy of Sciences · ATMedical University of Vienna · ATLudwig Boltzmann Institute for Rare and Undiagnosed Diseases · ATSt. Anne's University Hospital Brno · CZUniversity Hospital Brno · CZUniversity Hospital in Motol · CZUniversity of Freiburg · DE

Funding

Austrian Science Fund FWF Y 595European Research Council 310857
6 · The paper itself

Abstract

Specific granule deficiency (SGD) is a rare disorder characterized by abnormal neutrophils evidenced by reduced granules, absence of granule proteins, and atypical bilobed nuclei. Mutations in

Indexed as

MutationProteomeAdultBiomarkersCase-Control StudiesCCAAT-Enhancer-Binding ProteinsChildChild, PreschoolCytoplasmic GranulesEpitopesGlycoproteinsHumansLactoferrinLeukocyte DisordersMembrane GlycoproteinsMiddle AgedBiomarkersCCAAT-Enhancer-Binding ProteinsCEBPE protein, humanEpitopesGlycoproteinsLactoferrinMembrane GlycoproteinsProteomeC/EBPεgranule organizationneutrophil granulocytesprimary immunodeficiencyspecific granule deficiency

Identifiers

PMID29651288
PMCPMC5884887
OpenAlexW2795143802

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.